Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-02-26

Clinical Trial Update: Trial to Evaluate Efficacy and Safety of Combination of Diacerein and Celecoxib Administered in Patients With Knee OA [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating the combination of diacerein and celecoxib in knee osteoarthritis to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)
  • Diacerein (Diacerein)

Snippet

Sponsor: Whan-Seok Choi | Conditions: Knee Osteoarthritis | Phase 4 | Status: UNKNOWN